论文部分内容阅读
采用改良Ｌａｂｒｅｃｑｕｅ法，从人胎肝提取肝再生刺激因子（ＨＳＳ），并运用于治疗肝硬化病人（１５例），并设对照组（１５例）予以比较。结果：治疗组病例在自觉症状、体征及生化指标（ｒ－球蛋白、Ａ／Ｇ比值）等方面的改善明显优于对照组。并对ＨＳＳ的制备及应用作了介绍。
Liver regeneration stimulator (HSS) was extracted from human fetal liver by modified Labrecque method and used to treat cirrhosis patients (15 cases). The control group (15 cases) was compared. Results: The improvement of symptoms, signs and biochemical indexes (r-globulin, A / G ratio) in the treatment group was significantly better than that of the control group. The preparation and application of HSS were introduced.